Written informed consent provided prior to participation
Age 18 to 65 years
Medication-resistant auditory hallucinations, defined as:
* At least two adequate trials of antipsychotic medication
* At least one of these trials with an atypical antipsychotic medication
* At least five episodes of auditory hallucinations per day during the preceding month
* Stable antipsychotic medication for at least 6 weeks
Current treatment at the Psychiatric University Hospital Zurich (PUK), either in an outpatient clinic, day clinic, or inpatient ward
Sufficient knowledge of German to understand the study procedures and assessments
Ability to follow study procedures
You may not be if
Contraindications to TMS treatment, including cochlear implants, metallic devices close to the TMS coil, history of stroke, head injury, or seizures/epilepsy
History of epileptic convulsive seizures or epileptiform potentials in previous EEG examinations
TMS treatment within the 3 months preceding study inclusion
Known severe hypersensitivity or severe adverse reaction to TMS
Pregnancy or breastfeeding
Intention to become pregnant during the study
Major somatic comorbidities, such as renal failure, hepatic dysfunction, heart failure, or cardiovascular disease
Current treatment with any drug that lowers the seizure threshold
Known or suspected non-compliance, drug abuse, or alcohol abuse
Inability to follow study procedures, for example due to language problems, psychological disorder, dementia, or other conditions interfering with participation
Participation in another study involving investigational treatment within the 30 days preceding study inclusion or during the present study
Current electroconvulsive therapy (ECT)
Previous enrollment in the present study
Investigator, family member of the investigator, employee, or other dependent person
Contraindications or limitations related to the medical device as specified in the instructions for use
